Publications for Mattias Ekstedt
Co-author map based on ISI articles 2007-

Publications mentioned in social media 46 times*

Keywords

steatosis statins stage resistin progression pde patients nas nafld liver histological fibrosis fatty elevated disease clinical cirrhosis biopsy baseline ac

Journal Articles

G. Musso, R. Gambino, J.H. Tabibian, Mattias Ekstedt, Stergios Kechagias, M. Hamaguchi, R. Hultcrantz, H. Hagstrom, S.K. Yoon, P. Charatcharoenwitthaya, J. George, F. Barrera, S. Haflidadottir, E.S. Bjornsson, M.J. Armstrong, L.J. Hopkins, X. Gao, S. Francque, A. Verrijken, Y. Yilmaz, K.D. Lindor, M. Charlton, R. Haring, M.M. Lerch, R. Rettig, H. Volzke, S. Ryu, G. Li, L.L. Wong, M. Machado, H. Cortez-Pinto, K. Yasui and M. Cassader
  Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
 
Altmetric usage: 41

  PLoS Medicine, 2014, 11(7), e1001680.
   Fulltext  PDF  

Joel Johansson, Simone Ignatova and Mattias Ekstedt
  Pinworm infestation mimicking crohns' disease.
 
Altmetric usage: 4

  Case Reports in Gastrointestinal Medicine, 2013, 2013, 706197.

Christoffer Sjöwall, Kristina Cardell, Maria I Bokarewa, Helena Enocsson, Mattias Ekstedt, Liselott Lindvall, Aril Frydén and Sven Almer
  High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation
  Human Immunology, 2012, 73(4), 382-388.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Mattias Ekstedt, Lennart E Franzén, Ulrik L Mathiesen and Stergios Kechagias
  Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
  Scandinavian Journal of Gastroenterology, 2012, 47(1), 108-115.
 Web of Science® Times Cited: 4

E A Boström, Mattias Ekstedt, Stergios Kechagias, Christoffer Sjöwall, M I Bokarewa and Sven Almer
  Resistin is Associated with Breach of Tolerance and Anti-nuclear Antibodies in Patients with Hepatobiliary Inflammation
 
Altmetric usage: 1

  Scandinavian Journal of Immunology, 2011, 74(5), 463-470.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Mattias Ekstedt, Lennart E Franzén, Marika Holmqvist, Preben Bendtsen, Ulrik L Mathiesen, Göran Bodemar and Stergios Kechagias
  Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease
  Scandinavian Journal of Gastroenterology, 2009, 44(3), 366-374.
 Web of Science® Times Cited: 26

Mattias Ekstedt, Lennart E. Franzén, Ulrik L. Mathiesen, Göran Bodemar and Stergios Kechagias
  The clinical relevance of the Nonalcoholic Fatty Liver Disease Activity Score (NAS) in predicting fibrosis progression
  , 2008, , .

Bengt Norén, Olof Dahlqvist Leinhard, Peter Lundberg, Sven Almer, Stergios Kechagias, Mattias Ekstedt, Lennart Franzén, Staffan Wirell and Örjan Smedby
  Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy
  European Journal of Radiology, 2008, 66(2), 313-320.
 Web of Science® Times Cited: 15

V Ratziu, E Bugianesi, J Dixon, E Fassio, Mattias Ekstedt, F Charlotte, Stergios Kechagias, T Poynard and R Olsson
  Histological progress of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability.
  Alimentary Pharmacology and Therapeutics, 2007, 26, 821-830.
 Web of Science® Times Cited: 33

Mattias Ekstedt, Lennart E Franzén, Ulrik L Mathiesen, Marika Holmqvist, Göran Bodemar and Stergios Kechagias
  Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.
  Journal of Hepatology, 2007, 47(1), 135-141.
 Web of Science® Times Cited: 90

Mattias Ekstedt, Lennart E Franzén, Ulrik L Mathiesen, Lars Thorelius, Marika Holmqvist, Göran Bodemar and Stergios Kechagias
  Long-term follow-up of patients with NAFLD and elevated liver enzymes.
  Hepatology, 2006, 44(4), 865-873.
 Web of Science® Times Cited: 622

L. Franzen, Mattias Ekstedt, Stergios Kechagias, L. Bodin, R.N. Fiorini, J. Kirtz, B. Periyasamy, Z. Evans, J. Haines, G. Cheng, C. Polito, D. Rodwell, X. Zhou, C. Campbell, J. Birsner, M.G. Schmidt, D. Lewin and K.D. Chavin
  Letter to the editor (multiple letter)
  Clinical Transplantation, 2005, 19(4), 571.

Lennart E Franzén, Mattias Ekstedt, Stergios Kechagias and Lennart Bodin
  Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting.
  Modern Pathology, 2005, 18(7), 912-916.
 Web of Science® Times Cited: 55

Stergios Kechagias, Mattias Ekstedt, UL Mathiesen and L Franzen
  New reference interval for ALAT does not identify subclinical liver disease. Lower limit than the proposed should be used for medical considerations!
  Läkartidningen, 2004, 101, 2884-2887.

Conference Articles

Mikael Forsgren, Mattias Ekstedt, Olof Dahlqvist Leinhard, O. Andregård, Nils Dahlström, Stergios Kechagias, Sven Almer, Örjan Smedby, Peter Lundberg and Johan Kihlberg
  Prospective evaluation of liver steatosis comparing stereological point-counting biopsy analysis and 1H MRS
  ISMRM 20th Annual Meeting & Exhibition, 5-11 May, 2012, Melbourne, Australia, 2012.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.